Each patient was given a record card with instructions to enter the number of bowel actions and the consistency of the motion each day for one month. On studying these it became clear that only 23 of the patients had diarrhoea attacks of sufficient frequency for any conclusion to be drawn regarding the benefit from the treatments they were to be given. This is in accord with the findings of Feggetter and Pringle (1963) that routine observation failed on many occasions to confirm the severity of diarrhoea complained of by patients.
Diarrhoea may be defined as a deviation from established bowel rhythm characterized by an increase in frequency and fluidity of the stools. It is thought that a patient's request for relief from diarrhoea is as important as the physician's opinion in deciding whether to treat it or not. In this trial it was the patient who decided when and how often to take a course of treatment.
Diarrhoea occurring after complete vagotomy with a drainage procedure has been variously described, but may be roughly divided into three types (Cox and Bond, 1964 (Hock, 1961) 
Method
Each patient was given a record card with instructions to enter the number of bowel actions and the consistency of the motion each day for one month. On studying these it became clear that only 23 of the patients had diarrhoea attacks of sufficient frequency for any conclusion to be drawn regarding the benefit from the treatments they were to be given. This is in accord with the findings of Feggetter and Pringle (1963) that routine observation failed on many occasions to confirm the severity of diarrhoea complained of by patients.
These 23 patients were asked to record the number and consistency of their motions and also the number of tablets taken and their efficacy in controlling the diarrhoea over a further period of three months. The patients were each given three treatments, to be taken for one month in an order dictated by random selection. These consisted of tablets, identical in appearance and taste, of Lomotil 5 mg., of codeine phosphate 15 mg., and of placebo that was identical in appearance to both drugs but contained sucrose.
The patients were instructed to take one tablet as soon as an attack of diarrhoea began and to continue to take a tablet morning, noon, and night for three days, then stop. If the diarrhoea continued they were told to start again after a lapse of three days. All the patients except two complied with these instructions. They were seen once a month and were asked whether the tablets had been of value or had caused any sideeffects; a new supply was given and the tablets remaining from the previous month's treatment were collected so as to avoid confusion. 2. Clinician's Opinion.-At the completion of the threemonthly period the record cards were studied by an independent observer and were placed in order of greatest effect, as judged by the frequency and consistency of bowel actions on the day before the diarrhoea started (designated Day 0), the day on which diarrhoea began and treatment was started (Day 1), and the second and third days of treatment (Day 2 It will be seen that the patient's assessment closely corresponded with that of the clinician. In both assessments Lomotil was marginally preferred to codeine phosphate, though the difference was not significant. Both treatments were significantly better than the placebo (X2 with two degrees of freedom =28.9; P<0.001).
Duration of Diarrhoea.-In all but one case the attack of diarrhoea ceased within three days of starting treatment. In this case the patient's bowels moved six to eight times daily and failed to show any improvement with treatment. Lomotil, given each day for a week in the recommended dose of 15 mg./day, did not relieve his symptoms.
Side-effects.-Side-effects were noted in 5 out of the 23 patients while they were taking Lomotil. Two complained of dryness of the mouth, two of nausea with headaches, and one woman had attacks of vomiting and dizziness on each of the three occasions in the month that she took Lomotil. One patient taking the placebo complained of abdominal pain. Codeine did not cause any side-effects.
Discussion
That Lomotil has a constipating effect cannot be doubted, but on the basis of this trial it has no significant advantage over codeine phosphate. It also gives rise to side-effects. It is doubtful if either treatment has a place in the management of post-vagotomy diarrhoea of the episodic type, because it has been found that these attacks are generally of short duration and that it is the unexpected urgency associated with the first loose motion which causes most distress. Because of the lack of warning, regular prophylaxis would be necessary, and only 2 out of the 16 patients with this type of diarrhoea said that they would prefer to take a constipating agent for this reason rather than accept the situation as it was. Of the other seven patients who had continual looseness of motions, one, as stated, did not benefit from either treatment, and the other six were given a regular supply of whichever tablet was considered to be most effective (Lomotil 4, codeine 2). Three have been markedly improved and three marginally so.
Summary
Out of 154 patients who had undergone total vagotomy with drainage 23 had diarrhoea and were the subjects of a controlled trial of Lomotil. Although Lomotil proved a satisfactory constipating agent, it is judged to be of little value in either the prophylaxis of sudden episodic attacks or the treatment of more continuous post-vagotomy diarrhoea. Side-; effects were noted in S of the 23 patients.
